Supplementary Figure from <i>FOXM1</i> Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer

Shaoxing Guan,Xi Chen,Youhao Chen,Wen Xie,Heng Liang,Xia Zhu,Yunpeng Yang,Wenfeng Fang,Yan Huang,Hongyun Zhao,Wei Zhuang,Shu Liu,Min Huang,Xueding Wang,Li Zhang

crossref（2023）

引用 0|浏览9

暂无评分

摘要

Supplementary Figure from FOXM1 Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure from &lt;i&gt;FOXM1&lt;/i&gt; Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer

Supplementary Figure from <i>FOXM1</i> Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer